Skip to main content

WHOAPI-058: Tenofovir disoproxil fumarate

Product details
WHO Product ID
WHOAPI-058
Status
Prequalified
Date of prequalification
Basis of listing
Prequalification - Standard
Therapeutic area
HIV/AIDS
Type
None
Grade
Standard
INN
Tenofovir disoproxil fumarate
Confirmation of WHO API prequalification document (version date)
Applicant organization
Sun Pharmaceutical Industries Limited
Sun House, 201 B/1, Western Express Highway, Goregaon (East)
Mumbai,
400063
India
APIMF Version Number
Tenofovir Disoproxil Fumarate/OP/05/Oct-2020
Tenofovir Disoproxil Fumarate/RP/05/Oct-2020
Tenofovir Disoproxil Fumarate/RP/005/Oct-2020/Amend 07-Apr-2021
Tenofovir Disoproxil Fumarate/OP/005/Oct-2020/Amend 25-Nov-2021
Tenofovir Disoproxil Fumarate/RP/005/Oct-2020/Amend 25-Nov-2021
Tenofovir Disoproxil Fumarate/OP/005/Oct-2020/Amend 23-May-2023
Tenofovir Disoproxil Fumarate/RP/005/Oct-2020/Amend 23-May-2023
Tenofovir Disoproxil Fumarate/RP/005/Oct-2020/Amend 10-August-2023
Tenofovir Disoproxil Fumarate/OP/005/Oct-2020/Amend 18-Mar-2024
Tenofovir Disoproxil Fumarate/RP/005/Oct-2020/Amend 18-Mar-2024
Product Grades
API specification number
AS007151 version 5.0
Storage condition
Store in a refrigerator (2 °C to 8 °C), protect from moisture, protect from ligh
Storage period (months)
48
Duration type
Retest period
Packaging
Primary packaging: LDPE bag; Middle bag: HMHDPE/LDPE/LLDPE; Outer bag: polyester film/Alu/LDPE placed in a HDPE drum
API Manufacturing Site(s)
Sun Pharmaceutical Industries Limited
Village Toansa, P.O. Rail Majra, Dist. S.B.S. Nagar (Nawanshahar)
Punjab
144 533
India

.